Sunshine Biopharma Inc. SEC filings SBFMW

Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Sunshine Biopharma Inc. SEC filings
Form Description Filed Period
10-K Annual report Apr 3, 2026 Dec 31, 2025
10-K Annual report Apr 1, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K Annual report Apr 4, 2023 Dec 31, 2022
10-K Annual report Mar 21, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report May 1, 2020 Dec 31, 2019
10-K Annual report Apr 12, 2019 Dec 31, 2018
10-K Annual report Apr 2, 2018 Dec 31, 2017
10-K Annual report Apr 17, 2017 Dec 31, 2016
10-K Annual report Mar 25, 2016 Dec 31, 2015
10-K Annual report Mar 11, 2015 Dec 31, 2014
10-K Annual report Mar 19, 2014 Dec 31, 2013
10-K Annual report Mar 15, 2013 Dec 31, 2012
10-K Annual report Mar 19, 2012 Dec 31, 2011
10-K Annual report Mar 30, 2011 Dec 31, 2010
10-KT Transition report Mar 30, 2010 Dec 31, 2009
10-K Annual report Oct 30, 2009 Jul 31, 2009

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SBFM (Nasdaq), SBFMW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CO
Headquarters
Fort Lauderdale, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1402328
Former names
Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.